Anatara Lifesciences Ltd (ASX:ANR) Progressing Towards First Human Clinical Studies
Anatara Lifesciences (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in humans and animals is pleased to provide this update on clinical trial activities.